Vaxart Announces Selection of its Oral COVID-19 Vaccine Lead Candidate

Ads

You May Also Like

Incysus Scientific Co-Founder to Present at Immuno-Oncology Summit

HAMILTON, Bermuda, Aug. 23, 2017 (GLOBE NEWSWIRE) -- Incysus, Ltd, a biopharmaceutical company focused ...

Summit Therapeutics plc : Interim 24-Week Data from PhaseOut DMD

Summit Therapeutics plc('Summit', or 'the Company') EZUTROMID SIGNIFICANTLY REDUCED MUSCLE DAMAGE IN DMD PATIENTS ...